M Platten

Summary

Affiliation: University of Heidelberg
Country: Germany

Publications

  1. ncbi Painful neuropathy due to intraneural leukemic spread in a patient with acute myeloid leukemia
    M Platten
    Department of Neurooncology, University Hospital of Heidelberg, Heidelberg, Germany
    Neurology 69:707. 2007
  2. ncbi [Treatment of brain tumor patients: hyperthermia, hyperbaric oxygenation, electric fields or nanoparticles]
    M Platten
    Abteilung Neuroonkologie, Universitatsklinikum Heidelberg, INF 400, 69120 Heidelberg, Deutschland
    Nervenarzt 83:982-7. 2012
  3. ncbi Does age matter? - A MRI study on peritumoral edema in newly diagnosed primary glioblastoma
    Clemens Seidel
    Department of Neurooncology University Clinic Heidelberg, Germany
    BMC Cancer 11:127. 2011
  4. ncbi [Neuroradiological response criteria for malignant gliomas]
    M Bendszus
    Abteilung Neuroonkologie, Universitatsklinikum Heidelberg, Im Neuenheimer Feld 400, 69120, Heidelberg, Deutschland
    Nervenarzt 81:950-5. 2010
  5. ncbi Tryptophan degradation in autoimmune diseases
    C A Opitz
    Department of Neurooncology, University Hospital of Heidelberg, Germany
    Cell Mol Life Sci 64:2542-63. 2007
  6. ncbi Primary cerebral non-Langerhans cell histiocytosis: MRI and differential diagnosis
    U Ernemann
    Department of Neuroradiology, University Hospital Tubingen, Hoppe Seyler Strasse 3, 72076 Tubingen, German
    Neuroradiology 44:759-63. 2002

Collaborators

Detail Information

Publications6

  1. ncbi Painful neuropathy due to intraneural leukemic spread in a patient with acute myeloid leukemia
    M Platten
    Department of Neurooncology, University Hospital of Heidelberg, Heidelberg, Germany
    Neurology 69:707. 2007
  2. ncbi [Treatment of brain tumor patients: hyperthermia, hyperbaric oxygenation, electric fields or nanoparticles]
    M Platten
    Abteilung Neuroonkologie, Universitatsklinikum Heidelberg, INF 400, 69120 Heidelberg, Deutschland
    Nervenarzt 83:982-7. 2012
    ..In this review we review these clinical therapeutic approaches...
  3. ncbi Does age matter? - A MRI study on peritumoral edema in newly diagnosed primary glioblastoma
    Clemens Seidel
    Department of Neurooncology University Clinic Heidelberg, Germany
    BMC Cancer 11:127. 2011
    ..As older age is a negative prognostic marker and as VEGF expression is reported to be increased in primary glioblastoma of older patients, age-related differences in the extent of peritumoral edema have been assessed...
  4. ncbi [Neuroradiological response criteria for malignant gliomas]
    M Bendszus
    Abteilung Neuroonkologie, Universitatsklinikum Heidelberg, Im Neuenheimer Feld 400, 69120, Heidelberg, Deutschland
    Nervenarzt 81:950-5. 2010
    ..Thus both neuroradiologists and neurologists/neurooncologists need to be aware of and experienced in applying these criteria when treating patients with malignant gliomas to be able to correctly assess the response to therapy...
  5. ncbi Tryptophan degradation in autoimmune diseases
    C A Opitz
    Department of Neurooncology, University Hospital of Heidelberg, Germany
    Cell Mol Life Sci 64:2542-63. 2007
    ..Possible therapeutic approaches for autoimmune disorders targeting Trp degradation are presented, and key issues relevant for the development of such therapeutic strategies are discussed...
  6. ncbi Primary cerebral non-Langerhans cell histiocytosis: MRI and differential diagnosis
    U Ernemann
    Department of Neuroradiology, University Hospital Tubingen, Hoppe Seyler Strasse 3, 72076 Tubingen, German
    Neuroradiology 44:759-63. 2002
    ..Whereas the cutaneous form of juvenile xanthogranuloma is usually benign and self-limited, central nervous system involvement is associated with high morbidity and mortality and might therefore be considered a separate clinical entity...